Consolidated statement of changes in equity

Equity attributable to owners of the company

Non-

controlling

interests

(NCI)

$m

Total

equity

$m

Share capital

Reserves and surplus

Equity

attributable

to owners

of the

company

$m

Number of shares

Amount

$m

Retained

earnings

$m

Transactions

with NCI

reserve

$m

Other

components

of equity

$m

Total

$m

As of 1 April 2023

6,839,896,081

3,420

3,902

(929)

(2,758)

215

3,635

173

3,808

(Loss)/profit for the year

(165)

(165)

(165)

76

(89)

Other comprehensive gain/(loss) 

0

(1,141)

(1,141)

(1,141)

(32)

(1,173)

Total comprehensive income/(loss)

(165)

(1,141)

(1,306)

(1,306)

44

(1,262)

Transactions with owners of equity 

Employee share-based payment reserve

(1)

2

1

1

1

Purchase of own shares (net)

1

1

1

1

Cancellation of deferred shares

(3,081,744,577)

(1,541)

1,541

1,541

Ordinary shares buy-back programme (refer to note 5(d))

(7,389,855)

(4)

(9)

(37)

(46)

(50)

(50)

Transactions with NCI3

91

91

91

(12)

79

Dividend to owners of the company

(212)

(212)

(212)

(212)

Dividend (including tax) to NCI1

(65)

(65)

As of 31 March 2024

3,750,761,649

1,875

5,056

(838)

(3,933)

285

2,160

140

2,300

Profit for the year

220

220

220

108

328

Other comprehensive income

1

178

179

179

42

221

Total comprehensive income

221

178

399

399

150

549

Opening reserve adjustment for hyperinflation2

246

246

246

62

308

Transactions with owners of equity

Employee share-based payment reserve

(4)

(1)

(5)

(5)

(5)

Purchase of own shares (net)

8

8

8

8

Ordinary shares buy-back programme (refer to note 5(d))

(80,231,773)

(40)

(120)

60

(60)

(100)

(100)

Transactions with NCI3

7

7

7

(1)

6

Dividend to owners of the company (refer to note 5(a))   

(229)

(229)

(229)

(229)

Dividend (including tax) to NCI1

(62)

(62)

As of 31 March 2025

3,670,529,876

1,835

4,924

(831)

(3,442)

651

2,486

289

2,775